Hippocampal neural network (None (no widely used abbreviation in molecular targeting context))

The **hippocampal neural network** is a complex functional assembly of neurons—chiefly within the dentate gyrus, cornu ammonis (CA) subfields (CA1/CA3), and entorhinal cortex—that mediates memory formation, retrieval, and spatial navigation[1][3][5][7]. This network is organized by intricate excitatory and inhibitory connections, recurrent circuits (particularly within CA3 for pattern completion), and modulated by neuromodulatory systems (e.g., GPCRs, ion channels, neuropeptides)[2]. Disturbances in the hippocampal network underlie major neurocognitive disorders including Alzheimer’s disease and epilepsy[5][6][7]. As an anatomical and functional ensemble, it is studied via electrophysiology, imaging, and computational modeling rather than classical pharmacological targeting[3][7]. Components such as neuron-type subpopulations, neurotransmitter receptors, and ion channels are true molecular targets within the broader network[2][8]. If you seek a canonical drug target, specify an individual receptor, ion channel, or neuron subtype within the hippocampal network (e.g., "NMDA receptor in hippocampal CA1 pyramidal cell"), rather than the entire network[2][7][8].

Other names

Hippocampal networkHippocampal circuitHippocampal formation (broader anatomical term)Hippocampal CA3/CA1/DG circuit (for subregion-specific networks)

Not applicable for the network as a target. Drugs intervene via modulation of neuronal firing, synaptic plasticity, neurotransmitter release, excitatory/inhibitory balance by acting upon membrane receptors/channels/enzymes within network neurons (e.g., NMDA, AMPA, GABA_A, muscarinic receptors)[2][5].